TH9619
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TH9619, covering 2026-01-28 to 2026-01-28. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors [Phase 1, Phase 2]